Cargando…
Stability of extemporaneously compounded amiloride nasal spray
Anxiety disorders (AD) are the most common mental conditions affecting an estimated 40 million adults in the United States. Amiloride, a diuretic agent, has shown efficacy in reducing anxious responses in preclinical models by inhibiting the acid-sensing ion channels (ASIC). By delivering amiloride...
Autores principales: | Yellepeddi, Venkata, Sayre, Casey, Burrows, Anna, Watt, Kevin, Davies, Simon, Strauss, John, Battaglia, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351165/ https://www.ncbi.nlm.nih.gov/pubmed/32649677 http://dx.doi.org/10.1371/journal.pone.0232435 |
Ejemplares similares
-
Pharmacokinetics of intranasal amiloride in healthy volunteers
por: Yellepeddi, Venkata K., et al.
Publicado: (2023) -
Stability of Diazoxide in Extemporaneously Compounded Oral Suspensions
por: Friciu, Mihaela, et al.
Publicado: (2016) -
Stability of gabapentin in extemporaneously compounded oral suspensions
por: Friciu, Mihaela, et al.
Publicado: (2017) -
The Extent of Extemporaneous Preparation and Regulatory Framework of Extemporaneous Compounding in Latvia
por: Kiseļova, Olga, et al.
Publicado: (2019) -
Extemporaneously compounded medicines [Correction]
Publicado: (2017)